Immunoprophylaxis of respiratory syncytial virus disease

被引：8
|
作者：
Sánchez, PJ [1 ]
机构：
[1] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75235 USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2000年 / 19卷 / 08期
关键词：
respiratory syncytial virus; immunoprophylaxis; monoclonal antibody; intravenous immunoglobulin; polyclonal antibody;
D O I：
10.1097/00006454-200008000-00033
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：791 / 801
页数：11
相关论文
共 50 条
  • [41] Respiratory syncytial virus: Early immunoprophylaxis in NICU preterm infants using palivizumab
    Bonaparte, J
    Wu, SY
    Pyati, S
    PEDIATRIC RESEARCH, 2003, 53 (04) : 311A - 311A
  • [42] Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease - Discussion
    Cabalka, AK
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (01) : S45 - S45
  • [43] Severity of respiratory syncytial virus disease
    Fisher, RG
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (10) : 1030 - 1031
  • [44] PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS DISEASE
    Carrera, G.
    D'alterio, R.
    Leone, G.
    Zambetti, C.
    MINERVA PEDIATRICA, 2013, 65 (05) : 505 - 512
  • [45] Outcomes of Respiratory Syncytial Virus Immunoprophylaxis in Infants Using an Abbreviated Dosing Regimen of Palivizumab
    Lavoie, Pascal M.
    Solimano, Alfonso
    Taylor, Richard
    Kwan, Eddie
    Claydon, Jennifer
    Turvey, Stuart E.
    Marr, Nico
    JAMA PEDIATRICS, 2016, 170 (02) : 174 - 176
  • [46] The Logistics and Coordination of Respiratory Syncytial Virus Immunoprophylaxis Use Among US Pediatric Specialists
    Wong, Pierre C.
    Parimi, Prabhu S.
    Domachowske, Joseph B.
    Friedman, Deborah M.
    Marcus, Michael G.
    Garcia, Daniel F.
    La Via, William V.
    Syed, Iqra A.
    Szabo, Shelagh M.
    McLaurin, Kimmie K.
    Kumar, Veena R.
    CLINICAL PEDIATRICS, 2016, 55 (13) : 1230 - 1241
  • [47] EFFECT OF PASSIVE IMMUNOPROPHYLAXIS ON THE OUTCOME OF EXPERIMENTALLY INDUCED INFECTION WITH RESPIRATORY SYNCYTIAL VIRUS (RSV)
    DHAR, R
    WONG, DT
    HOVEY, KA
    OGRA, PL
    PEDIATRIC RESEARCH, 1985, 19 (04) : A291 - A291
  • [48] Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthma
    Carroll, Kecia N.
    Gebretsadik, Tebeb
    Escobar, Gabriel J.
    Wu, Pingsheng
    Li, Sherian Xu
    Walsh, Eileen M.
    Mitchel, Ed
    Sloan, Chantel D.
    Dupont, William D.
    Hartert, Tina V.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (01) : 66 - +
  • [49] Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis
    Groothuis, Jessie R.
    Hoopes, J. Michael
    Hemming, Val G.
    ADVANCES IN THERAPY, 2011, 28 (02) : 110 - 125
  • [50] Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand
    Prasad, Namrata
    Read, M. Jonathan
    Jewell, Christopher
    Waite, Ben
    Trenholme, A. Adrian
    Huang, Q. Sue
    Grant, C. Cameron
    Newbern, E. Claire
    Hogan, B. Alexandra
    VACCINE, 2021, 39 (31) : 4383 - 4390
12345